| HOME >> BIOLOGY >> TECHNOLOGY |
CHELMSFORD, Mass., Aug. 28 /PRNewswire/ -- Magellan Biosciences, an emerging leader in clinical-diagnostics markets worldwide, announced that Steven E. Diamond, PhD, has joined the company as chief scientific officer. Dr. Diamond comes to Magellan from Siemens Medical Solutions Diagnostics (formerly Bayer Diagnostics), where he was vice president, research and development, for the point-of-care product lines: urinalysis, blood gas, and HbA1c (diabetes testing). In addition to internal product development, Dr. Diamond had an active role in the evaluation and development of external technologies to enhance and extend the company's products for near-patient testing.
"Steve has been a true leader in the point-of-care and near-patient- testing arena -- Magellan's primary focus areas for future growth. Under his stewardship, Bayer successfully developed and launched a suite of market- leading products for near-patient testing. He knows how to shepherd products from concept, through research and development, and onward to product launch - all the way to commercial success," said Magellan President and CEO, Robert J. Rosenthal, PhD. "And he joins Magellan at an ideal time in our company development. We continue to meet our growth goals, and have an excellent track record of developing and commercializing innovative platform products to improve outcomes and serve critical unmet needs in the clinical-diagnostic market. Recent product introductions include ESA's LeadCare(R) II point-of- care system, designed for community-based testing to identify rapidly children with elevated blood-lead levels; Dynex's DS2(TM) ELISA processing system, which brings the power of automation to hospital-based and other lower- throughput labs, and TREK's new Vizion(TM) system, which adds digital-imaging capability to its leading Sensititre(R) system for antibiotics-resistance testing.
Dr. Rosenthal continued, "Steve's charge is to help us build on this
success by leveraging our
'/>"/>
| SOURCE Magellan Biosciences Copyright©2007 PR Newswire. All rights reserved |